Literature DB >> 28268564

Automated detection of neovascularization for proliferative diabetic retinopathy screening.

Sohini Roychowdhury, Dara D Koozekanani, Keshab K Parhi.   

Abstract

Neovascularization is the primary manifestation of proliferative diabetic retinopathy (PDR) that can lead to acquired blindness. This paper presents a novel method that classifies neovascularizations in the 1-optic disc (OD) diameter region (NVD) and elsewhere (NVE) separately to achieve low false positive rates of neovascularization classification. First, the OD region and blood vessels are extracted. Next, the major blood vessel segments in the 1-OD diameter region are classified for NVD, and minor blood vessel segments elsewhere are classified for NVE. For NVD and NVE classifications, optimal region-based feature sets of 10 and 6 features, respectively, are used. The proposed method achieves classification sensitivity, specificity and accuracy for NVD and NVE of 74%, 98.2%, 87.6%, and 61%, 97.5%, 92.1%, respectively. Also, the proposed method achieves 86.4% sensitivity and 76% specificity for screening images with PDR from public and local data sets. Thus, the proposed NVD and NVE detection methods can play a key role in automated screening and prioritization of patients with diabetic retinopathy.

Entities:  

Mesh:

Year:  2016        PMID: 28268564     DOI: 10.1109/EMBC.2016.7590945

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Leptin activates the JAK/STAT pathway to promote angiogenesis in RF/6A cells in vitro.

Authors:  Le Zhang; Rong Li; Bing-Hui Wu; Ting-Ting Liang; Zhe Liu; Wei Ju; Yi Wang; Yu-Ting Wen; Ming-Cui Liu; Jun-Hui Du
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

2.  Sensitivity and specificity of automated analysis of single-field non-mydriatic fundus photographs by Bosch DR Algorithm-Comparison with mydriatic fundus photography (ETDRS) for screening in undiagnosed diabetic retinopathy.

Authors:  Pritam Bawankar; Nita Shanbhag; S Smitha K; Bodhraj Dhawan; Aratee Palsule; Devesh Kumar; Shailja Chandel; Suneet Sood
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.